---
title: "BeBetter Med Inc. (688759.SH)"
type: "quote"
locale: "en"
url: "https://longbridge.com/en/quote/688759.SH.md"
symbol: "688759.SH"
name: "BeBetter Med Inc."
industry: "Biotechnology"
---

# BeBetter Med Inc. (688759.SH)

| Item | Detail |
|------|--------|
| Industry | Biotechnology |
| Location | CN Market |
| Website | [www.bebettermed.cn](https://www.bebettermed.cn) |

## Company Profile

BeBetter Med Inc., a biopharmaceutical company, engages in the research and development, and sale of drugs for tumors, autoimmune diseases, and metabolic diseases. It is developing BEBT-908, a PI3K/HDAC dual-target small molecule inhibitor for antitumor; BEBT-209, a CDK4 highly selective CDK4/6 inhi...

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -340.67 | 81/83 | - | - | - |
| PB | 11.18 | 68/83 | 11.60 | 8.55 | 7.73 |
| Dividend Yield | 0.00% | - | - | - | - |

## References

- [Company Overview](https://longbridge.com/en/quote/688759.SH/overview.md) - Shareholders, executives, business segments
- [Financials](https://longbridge.com/en/quote/688759.SH/norm.md) - Income statement, balance sheet, cash flow, distribution plan
- [Topics & Discussions](https://longbridge.com/en/quote/688759.SH/topics.md) - Community topics and discussions

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.